Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Posterior tibial nerve stimulation to help bowel function after rectal cancer surgery

Official title: Randomized Clinical Trial Assessing the Efficacy and Safety of Transcutaneous Posterior Tibial Nerve Stimulation on Fecal Continence in Patients Undergoing Surgery for Rectal Neoplasia

Run by Althaia Xarxa Assistencial Universitària de Manresa · NCT07632196 · Data updated 2026-11-12

This trial tests whether posterior tibial nerve stimulation can improve fecal continence and quality of life for adults who had rectal cancer surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment84 (estimated)
SponsorAlthaia Xarxa Assistencial Universitària de Manresa
Academic / other
Locations2 sites (Manresa, Barcelona and 1 other locations)
StatusRecruiting
StartedFebruary 6, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJune 8, 2026
Trial IDNCT07632196 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who have undergone high anterior resection for rectal neoplasia and do not have active surveillance, ostomy, or contraindicating electronic implants or other exclusions.

Probably not a fit

Patients with contraindications to neuromodulation, ongoing surveillance strategies, or those without fecal incontinence may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares active posterior tibial nerve stimulation with a sham-like, subtherapeutic stimulation in adults who have undergone rectal cancer surgery. Outcomes focus on fecal incontinence, bowel function, sexual function, and overall quality of life. Participants are assigned 1:1 to the active or control arm, and symptoms are measured using LARS and Wexner scores. The study aims to determine safety and potential benefit of neuromodulation after rectal neoplasm surgery. Eligible participants include adults who had high anterior resection, while certain medical conditions or devices exclude participation.

Why it matters

Potential benefit: If successful, patients may experience better bowel control and improved quality of life after rectal cancer surgery.

How similar studies have gone: Previous research on posterior tibial nerve stimulation in bowel and pelvic floor disorders has shown some positive effects, but trials directly in post-rectal surgery patients are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Adult patients diagnosed with rectal neoplasia and who have undergone a high anterior rectal resection regardless of the surgical approach (open, laparoscopic, laparoscopic+TaTME or robotic+TaTME).

Exclusion Criteria:

* Patients not operated or within active surveillance strategy programs (watch \& wait)
* Patients with ostomy
* Patients with contraindications to the use of the neurostimulator:

  * Pacemaker / Defibrillator / Other electronic devices
  * History of heart problems
  * Propensity to excessive bleeding (coagulopathies)
  * Damage to the nervous system (epilepsy)
  * Current pregnancy
  * Infections or skin lesions
  * Severe vascular disorders
  * Active neoplasms.

Where it's running

  • Althaia Xarxa Assistencial Universitària de Manresa
    Manresa, Barcelona, Spain
    Recruiting
  • Xarxa Assistencial Universitària de Manresa, Althaia
    Manresa, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.